Dow Down 0.22% Nasdaq Up 0.14%

Celgene Corporation (CELG)

-NasdaqGS
91.62 Down 0.04(0.04%) 4:00PM EDT
|After Hours : 91.80 Up 0.18 (0.20%) 6:31PM EDT
Prev Close:91.66
Open:91.94
Bid:91.62 x 1000
Ask:91.80 x 200
1y Target Est:100.03
Beta:1.11
Next Earnings Date:23-Oct-14CELG Earnings announcement
Day's Range:90.93 - 91.99
52wk Range:66.85 - 93.35
Volume:2,631,363
Avg Vol (3m):4,624,950
Market Cap:73.25B
P/E (ttm):29.16
EPS (ttm):3.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CELG

Comparison

Symbol% ChgMkt Cap
CELGDown 0.04%73.25B
JNJDown 0.38%290.77B

Key Statistics

Forward P/E (1 yr):18.74
P/S (ttm):10.42
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.67
Quarterly EPS Est (Sep-14) :0.95
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.95

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback